Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2006, p. 1077-1080, Vol. 44, No. 3
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.3.1077-1080.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Tarja Heiskanen,1 and
Anja Siitonen1*
Enteric Bacteria Laboratory (EBL), National Public Health Institute (KTL), FIN-00300 Helsinki,1 Environmental and Food Research Laboratory, Municipal Joint Union for Public Health in the Hämeenlinna Region, FIN-13111 Hämeenlinna, Finland2
Received 22 September 2005/ Returned for modification 28 October 2005/ Accepted 22 December 2005
|
|
|---|
|
|
|---|
In this study, unserotypeable Y. enterocolitica strains (n = 67) isolated and identified by Finnish hospital laboratories were retested at the Enteric Bacteria Laboratory (EBL), National Public Health Institute, with API 20 E (bioMérieux, France) at 30°C and by slide agglutination with antisera against Y. enterocolitica O:3, O:5, O:8, and O:9 (Denka Seiken, Japan). The strains were also biotyped according to Wauters et al. (18), and 55 strains belonged to biotype (BT) 1A (data not shown). Of the remaining 12 strains, 11 were not biotypeable (at least two reactions diverged from the established biotypes), and one strain (IH 111767) was BT 3 but was unserotypeable (Table 1). Thus, their identification as Y. enterocolitica strains was considered doubtful. These strains were further tested for fermentation of sorbose and fucose (at 25°C for 24 and 48 h) and on Congo red-magnesium oxalate agar (CR-MOX test) (13). For comparison, five strains of BTs 1A, 3, and 4 were included (Table 1). The colony morphology of all 17 strains through a stereomicroscope (Olympus [Japan] SZH10 zoom stereomicroscope with an SZH-ILLK illumination base) was examined on cefsulodin-irgasan-novobiocin (CIN) agar (Oxoid) incubated at 30°C for 22 to 24 h and compared to those of Y. enterocolitica (ATCC 9610, NCTC 11176, and RH 4823 [BT 1A control strain of EBL, National Public Health Institute]), Y. mollaretii (ATCC 43969), Y. bercovieri (ATCC 43970), and Y. rohdei (ATCC 43380 and 43872) cultured and incubated in parallel.
|
View this table: [in a new window] |
TABLE 1. Further characterization of Y. enterocolitica strains identified by clinical laboratories
|
API 20 E identified 9 of the 12 doubtful strains as Y. enterocolitica with >90% certainty (Table 1). In contrast, sequencing revealed only one Y. enterocolitica strain (identical to ATCC 9610 and NCTC 11176) but five Y. mollaretii strains (0- to 1-nucleotide difference from ATCC 43969), five Y. bercovieri strains (0- to 3-nucleotide difference from ATCC 43970), and one Y. rohdei strain (identical to ATCC 43380). Based on the colony morphology on CIN agar, all of the Y. mollaretii strains and three of the five Y. bercovieri strains (IH 111501, IH 116025, and IH 116028) were tentatively identified as Y. mollaretii or Y. bercovieri, respectively, compared to the reference strains prior to any other testing (Table 1; Fig. 1). The microscopic examination of Y. mollaretii and Y. bercovieri colonies (approximately 1.5 mm in diameter) revealed characteristic erose edges and ground-glass appearance of the translucent zone surrounding the red center of the colonies (best visible in slightly oblique illumination). These features distinguished them from the colonies of Y. enterocolitica BT 1A (approximately 2 mm in diameter, larger center of the colony, and the surrounding zone devoid of ground-glass appearance), serotype O:3 (approximately <1 mm in diameter, smaller, deeper red center of the colony with a sharper border (Fig. 1), and serotype O:9 (data not shown). The rest of the non-Y. enterocolitica strains (IH 41571, IH 116003, and IH 111799) had variable colony morphology (Table 1) that clearly differed from the morphology of Y. enterocolitica. Of the 11 non-Y. enterocolitica strains, it was possible to avoid misidentification as Y. enterocolitica for all 11 strains by colony morphology, but only for 3 strains (IH 41571, IH 116003, and IH 111799) with API 20 E.
![]() View larger version (118K): [in a new window] |
FIG. 1. Differentiating between Y. enterocolitica, Y. bercovieri, and Y. mollaretii on CIN agar (incubation at 30°C, 22 to 24 h) through a stereomicroscope (black bar, 1 mm). (a) Y. enterocolitica O:3 (pathogenic serotype, BT 4) appears as characteristically small (approximately <1 mm in diameter), circular colonies with entire edge. The colonies have a small, deep red center (bull's eye) with a sharp border surrounded by a translucent or transparent zone. (b) Y. enterocolitica BT 1A (nonpathogenic biotype). Large (approximately 2 mm in diameter), circular colonies with slightly lighter red center surrounded by a translucent to milk-white zone are shown. The center of the colony is large compared to the surrounding zone and has a blurred border. (c) Y. bercovieri. Erose-edged, slightly irregular circular colonies (approximately 1.5 mm in diameter) are shown, with a medium-red (sometimes pitting) center with an erose border. The surrounding translucent zone has a characteristic ground-glass appearance (best visible by slightly oblique illumination). (d and e) Y. mollaretii. Slightly irregular circular colonies (approximately 1.5 mm in diameter) are shown; a medium-red, diffuse center with no sharp borderline is visible. The surrounding translucent to milk-white zone has a characteristic ground-glass appearance (best visible in slightly oblique illumination). Two types exist: mucoid, with a smoother and more convex appearance (d) and a flat, dry, more irregular- and erose-edged colony (e). It has been noticed in EBL that approximately half of the incoming Y. mollaretii strains have a smooth, mucoid colony type and the other half have a dry, flat colony type (unpublished data). (f) Y. enterocolitica O:5,27 (pathogenic serotype). Circular, usually erose-edged (almost starlike) colonies (approximately 1 to 1.5 mm in diameter) are shown. A small, deep-red center with a slightly blurred border is visible. The surrounding translucent or transparent zone is large, compared to the center (as with Y. enterocolitica O:3), and has a ground-glass appearance.
|
The cross-reactions of the commercial antisera in serotyping are typical of Y. enterocolitica-like strains and Y. enterocolitica BT 1A (1, 19). In EBL in 2000, the nonserotypeable strains represented about 40% of the incoming Y. enterocolitica strains (7). Therefore, building the identification of Y. enterocolitica solely on the use of these sera, together with a diagnostic kit like API 20 E, is inadequate. For laboratories that have limited capacity for biotyping, the simplest way to avoid misidentifications is to compare the colony morphology of a API 20 E-identified Y. enterocolitica strain with the Y. enterocolitica control strains representing serotypes and/or biotypes O:3/4, O:5,27/2 or O:5,27/3, O:8/1B, O:9/2, O:9/3, and BT 1A.
The probe YeO:3RS contains a region upstream of the Y. enterocolitica O-antigen cluster, a repeated sequence (RS) that is present in multiple copies in the genome. In our previous study (6), the RS was shown to be present only in the genome of the "European" pathogenic serotypes (namely, O:3, O:5,27, O:9, O:1, and O:2) of Y. enterocolitica. The sequence was absent from the genomes of other Y. enterocolitica serotypes and Yersinia species, resulting in a weak or incomplete typing pattern of those strains in that study. The current results are in accordance with the previous observations; none of the Y. enterocolitica-like strains were typeable with the probe compared to the complete typing pattern of the "European" pathogenic bioserotypes in this study. The latter strains were also clearly positive by a CR-MOX test (Table 1).
To summarize, a simple scheme for identification of Y. enterocolitica-like strains is presented. Without accurate identification, already in the primary diagnostics, it is impossible to gain insight into the true clinical significance of Y. enterocolitica-like species. Although the advanced molecular methods are constantly developed, they still may not be available in many routine clinical microbiology laboratories. Therefore, it was interesting to notice how easily the straightforward comparison of the colony morphology of Yersinia isolates can effectively prevent the misidentification of a strain as Y. enterocolitica.
Present address: Central Hospital of Lapland, FIN-96400 Rovaniemi, Finland. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»